1. Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence.
- Author
-
Cimmino, Giovanni, Loffredo, Francesco S., De Rosa, Gennaro, and Cirillo, Plinio
- Subjects
ACUTE coronary syndrome ,ANTI-inflammatory agents ,COLCHICINE ,CARDIOVASCULAR diseases ,ISCHEMIC stroke ,THALASSEMIA - Abstract
Several lines of evidence have clearly indicated that inflammation plays a pivotal role in the development of atherosclerosis and of its thrombotic complications such as acute coronary syndromes or ischemic stroke. Thus, it has been postulated that the use of anti-inflammatory agents might be extremely useful to improve cardiovascular outcome. Recently, increasing attention has been reserved to one of the oldest plant-derived drugs still in use in clinical practice, colchicine that has been used as drug to treat inflammatory diseases such gout or Mediterranean fever. To date, current guidelines of the European Society of Cardiology have included colchicine as first line choice for treatment of acute and recurrent pericarditis. Moreover, several studies have investigated its role in the clinical scenarios of cardiovascular disease including chronic and acute coronary syndromes with promising results. In this review, starting from a description of the mechanism(s) involved behind its anti-inflammatory effects, we give an overview on its potential effects in atherothrombosis and finally present an updated overview of clinical evidence on the role of this drug in cardiovascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF